drugset / Trial / NCT01649648
Autologous Cord Blood Cells for Brain Injury in Term Newborns
Phase 1
Completed
2 enrolled
National University Hospital, Singapore
National Medical Research Council (NMRC), Singapore · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot study to test feasibility and safety of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood during the first 3 days of age if the baby is born with signs of brain injury. The cord blood used is fresh (not frozen and then thawed).
Timeline
- Start
- 2011-09
- Primary completion
- 2013-11
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous cord blood | Cell therapy | — | — |